Stress and drug resistance in cancer

Abstract

Patients diagnosed with cancer often undergo considerable psychological distress, and the induction of the psychological stress response has been linked with a poor response to chemotherapy. The psychological stress response is mediated by fluctuations of the hormones glucocorticoids (GCs) and catecholamines. Binding to their respective receptors, GCs and the catecholamines adrenaline/noradrenaline are responsible for signalling a wide range of processes involved in cell survival, cell cycle and immune function. Synthetic GCs are also often prescribed as co-medication alongside chemotherapy, and increasing evidence suggests that GCs may induce chemoresistance in multiple cancer types. In this review, we bring together evidence linking psychological stress hormone signalling with resistance to chemo- and immune therapies, as well as mechanistic evidence regarding the effects of exogenous stress hormones on the efficacy of chemotherapies.

Keywords

Cancer / catecholamines / dexamethasone / drug resistance / glucocorticoids

References

[1] O’connor TM,Shanahan F.The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia..QJM2000;93:323-33

[2] Smith SM.The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress..Dialogues Clin Neurosci2006;8:383-95 PMCID:PMC3181830

[3] Vanltallie TB.Stress: A risk factor for serious illness..Metabolism2002;51:40-5

[4] Chung S,Kim K.Circadian rhythm of adrenal glucocorticoid: Its regulation and clinical implications..Biochim Biophys Acta2011;1812:581-91

[5] Oakley RH.The Biology of the Glucocorticoid Receptor: New Signaling Mechanisms in Health and Disease..J Allergy Clin Immunol2013;132:1033-44 PMCID:PMC4084612

[6] Newton R.Separating transrepression and transactivation: A distressing divorce for the glucocorticoid receptor?.Mol Pharmacol2007;72:799-809

[7] Kadmiel M.Glucocorticoid receptor signaling in health and disease..Trends Pharmacol Sci2013;34:518-30 PMCID:PMC3951203

[8] Newton R.Molecular mechanisms of glucocorticoid action: what is important?.Thorax2000;55:603-13 PMCID:PMC1745805

[9] Cain DW.Immune regulation by glucocorticoids..Nat Rev Immunol2017;17:233-47

[10] Grunberg SM.Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis..Ann Oncol2007;18:233-40

[11] Charmandari E,Chrousos G.Endocrinology of the stress response..Annu Rev Physiol2005;67:259-84

[12] Cole SW.Molecular Pathways: Beta-Adrenergic Signaling in Cancer..Clin Cancer Res2012;18:1201-06 PMCID:PMC3294063

[13] McGrogan BT,Carney DN.Taxanes, microtubules and chemoresistant breast cancer..Biochim Biophys Acta2008;1785:96-132

[14] Flint MS,Hood BL,Stewart NA.Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway..Psychoneuroendocrinology2009;34:1533-41

[15] Reeder A,Nazario L,Zhang A.Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage..Br J Cancr2015;112:1461-70 PMCID:PMC4453678

[16] Kastan MB.Cell-cycle checkpoints and cancer..Nature2004;432:316-23

[17] Jenkins FJ,Bovbjerg DH.Effects on DNA Damage and/or Repair Processes as Biological Mechanisms Linking Psychological Stress to Cancer Risk..J Appl Biobehav Res2014;19:3-23 PMCID:PMC4039216

[18] Flaherty RL,Fagan-Murphy A,Healy D.Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer..Breast Cancer Res2017;19: PMCID:PMC5366114

[19] Flint MS,Chambers WH.Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones..Psychoneuroendocrinology2007;32:470-9

[20] Mattern J,Herr I.Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy..Cancer Biol Ther2007;6:1345-54

[21] Feng Z,Zhang C,Wang J.Chronic restraint stress attenuates p53 function and promotes tumorigenesis..Proc Natl Acad Sci U S A2012;109:7013 PMCID:PMC3345015

[22] Mechetner E,Zonis S,Stroup R.Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin..Clin Cancer Res1998;4:389-98

[23] Su F,Zhu P,Jia W.Psychological stress induces chemoresistance in breast cancer by upregulating mdr1..Biochem Biophys Res Commun2005;329:888-97

[24] Yao H,Wang M,Rappolee D.Adrenaline induces chemoresistance in HT-29 colon adenocarcinoma cells..Cancer Genet Cytogenet2009;190:81-7

[25] Sui M,Chen Z.Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors..Int J Cancer2006;119:712-7

[26] Fan W,Huang Y.Glucocorticoids selectively inhibit paclitaxel-induced apoptosis: mechanisms and its clinical impact..Curr Med Chem2004;11:403-11

[27] Moran TJ,Mikosz CA.The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells..Cancer Res2000;60:867-72

[28] Schorr K.Induction of bcl-xl Expression in Mammary Epithelial Cells Is Glucocorticoid-dependent but not Signal Transducer and Activator of Transcription 5-dependent..Cancer Res2000;60:5950-3

[29] Wu W,Brickley DR,Karrison T.Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells..Cancer Res2004;64:1757-64

[30] Mikosz CA,Sharkey MS,Conzen SD.Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1..J Biol Chem2001;276:16649-54

[31] Wu W,Zou M,Conzen SD.Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival..J Biol Chem2005;280:4117-24

[32] Melhem A,Fleming GF,Brickley DR.Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues..Clin Cancer Res2009;15:3196-204 PMCID:PMC4707040

[33] Sorrentino G,Zannini A,Bertolio R.Glucocorticoid receptor signalling activates YAP in breast cancer..Nat Commun2017;8:14073 PMCID:PMC5253666

[34] Dilruba S.Platinum-based drugs: past, present and future..Cancer Chemother Pharmacol2016;77:1103-24

[35] Costanzo ES,Lutgendorf SK.Biobehavioral Influences on Cancer Progression..Immunol Allergy Clin North Am2011;31:109-32 PMCID:PMC3011980

[36] Kang Y,Armaiz-Pena GN,Hu W.Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer..Clin Cancer Res2016;22:1713-24 PMCID:PMC4818718

[37] Shen J,Yu H,Liang Y.Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy..Cancer Med2016;5:2061-8 PMCID:PMC4884638

[38] Watts S,Mason J,Lewith G.Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates..BMJ Open2015;5:e007618 PMCID:PMC4679843

[39] Watkins JL,Nick AM,Kumar S.Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer..Cancer2015;121:3444-51 PMCID:PMC4575637

[40] Stringer-Reasor EM,Skor MN,Lengyel E.Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma..Gynecol Oncol2015;138:656-62 PMCID:PMC4556542

[41] Chen YX,Fu CC,Song LN.Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells..Endocr Relat Cance2010;17:39-50

[42] Li Z,Zou T,Li S.Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Kruppel-like factor 5 in triple-negative breast cancer..Oncotarget2017;8:11555-65 PMCID:PMC5355285

[43] Zheng HQ,Huang J,Dong JT.Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1..Oncogene2009;28:3702-13

[44] Xia H,Chen W,Chaudhury L.Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer..J Biol Chem2013;288:26731-40 PMCID:PMC3772219

[45] Liu R1,Zhou Z,Chen C.KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization..J Biol Chem2009;284:16791-8 PMCID:PMC2719315

[46] Shi M,Liu D,Hu M.Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells..J Pathol2012;228:148-57

[47] Lu YS,Chuang SE,Kuo ML.Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa..J Endocrinol2006;188:311-9

[48] Wang H,Rayburn ER,Rinehart JJ.Dexamethasone as a chemosensitizer for breast cancer chemotherapy: Potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics..Int J Oncol2007;30:947-53

[49] Herr I,Herzer K,Ridder R.Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas..Cancer Res2003;63:3112-20

[50] Petrella A,Festa M,Tosco A.Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction..Eur J Cancer2006;42:3287-93

[51] Yang N,Si-Ma H,Zhao W.Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis..Hepatogastroenterology2011;58:1730-5

[52] Gassler N,Wenger T,Dienemann H.Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo..Br J Cancer2005;92:1084-8 PMCID:PMC2361940

[53] Zhang C,Wenger T,Edler L.Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas..Int J Oncol2006;28:551-8

[54] Zhang C,Büchler P,Mattern J.Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer..BMC Cancer2006;6:61 PMCID:PMC1434760

[55] Yang F,Kemp CJ.Doxorubicin, DNA torsion, and chromatin dynamics..Biochim Biophys Acta2014;1845:84-9 PMCID:PMC3927826

[56] Chikamori K,Kozuki T,Ganapathi R.DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy..Curr Cancer Drug Targets2010;10:758-71

[57] Thorn CF,Marsh S,McLeod H.Doxorubicin pathways: pharmacodynamics and adverse effects..Pharmacogenetics Genomics2011;21:440-6 PMCID:PMC3116111

[58] Octavia Y,Gabrielson KL,Crijns HJ.Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies..J Mol Cell Cardiol2012;52:1213-25

[59] Gyorffy B,Jurchott K,Garber M.Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival..Oncogene2005;24:7542-51

[60] Wang Z,Lian X,Zhao S.Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis..Sci Rep2015;5:9301 PMCID:PMC4377623

[61] Smith L,O’Kane SL,Lind MJ.The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays..Mol Cancer Ther2006;5:2115-20

[62] Doroshow JH,Esworthy S,Burke T.Doxorubicin resistance conferred by selective enhancement of intracellular glutathione-peroxidase or superoxide-dismutase content in human mcf-7 breast-cancer cells..Free Radic Res Commun1991;12:779-81

[63] Wang XJ,Villeneuve NF,Zhao F.Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2..Carcinogenesis2008;29:1235-43 PMCID:PMC3312612

[64] Zhong Y,Sun Z,Li ZY.Drug Resistance Associates With Activation of Nrf2 in MCF-7/DOX Cells, and Wogonin Reverses it by Down-Regulating Nrf2-Mediated Cellular Defense Response..Mol Carcinog2013;52:824-34

[65] Kim SK,Kim MR,Kim HG.Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells..Free Radic Biol Med2008;45:537-46

[66] Mayerhofer M,Krauth MT,Bilban M.Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia..Cancer Res2004;64:3148-54

[67] Ramos-Gomez M,Dolan PM,Yamamoto M.Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice..Proc Natl Acad Sci U S A2001;98:3410-5 PMCID:PMC30667

[68] Rutz HP.Interference of glucocorticoids with apoptosis signaling and host-tumor interactions..Cancer Biol Ther2004;3:715-8

[69] Cook AM,Lake RA.Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies..Oncoimmunology2016;5:e1066062 PMCID:PMC4839331

[70] Stahn C.Genomic and nongenomic effects of glucocorticoids..Nat Clin Pract Rheumato2008;4:525-33

[71] Namani A,Wang XJ.Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer..Biochim Biophys Acta2014;1843:1875-85

[72] Damia G.Platinum Resistance in Ovarian Cancer: Role of DNA Repair..Cancers2019;11:119 PMCID:PMC6357127

[73] Flaherty RL,Fagan-Murphy A,Healy D.Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer..Breast Cancer Res2017;19:35 PMCID:PMC5366114

[74] Bucsek MJ,MacDonald CR,Evans L.beta-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8(+) T Cells and Undermines Checkpoint Inhibitor Therapy..Cancer Res2017;77:5639-51 PMCID:PMC5645237

[75] Nissen MD,Mattarollo SR.beta-Adrenergic Signaling Impairs Antitumor CD8(+) T-cell Responses to B-cell Lymphoma Immunotherapy..Cancer Immunol Res2018;6:98-109

[76] Madore J,Menzies AM,Wilmott JS.PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials..Pigment Cell Melanoma Res2015;28:245-53